All In MedTech

Company

Pfm Medical

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

From SEC filings.

We found no SEC financing filings under the name Pfm Medical, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors from funding announcements and the firms' own portfolio pages.

No 5%+ shareholder filings, SBIR grants or venture investors found under the name Pfm Medical.

Latest FDA decisions

Search the Clearance Tracker

6 more FDA decisions with a free account

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar
  • NCT05209828 · 149 participants · Start Apr 13, 2022 · Primary completion Mar 9, 2023

    Device: pfmmedical implantable vascular access ports · For: Vascular Access Port; Patient Satisfaction

    Sites: Heidelberg, Germany

8 more trials with a free account

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 230000
Jan 240000
Feb 242000
Mar 241000
Apr 243000
May 242000
Jun 240200
Jul 240000
Aug 240000
Sep 240200
Oct 240600
Nov 240200
Dec 242300
Jan 250100
Feb 251700
Mar 253000
Apr 254100
May 251000
Jun 250100
Jul 251500
Aug 251100
Sep 251900
Oct 250100
Nov 251700
Dec 2501000
Jan 260000
Feb 260400
Mar 260300
Apr 260300
May 260200
Jun 260900
Jul 260500
Aug 262200
Sep 260400
Oct 260200
Nov 260000

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

1 more in this ranking with a free account

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

4 more in this ranking with a free account

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

  • Z-2526-2026 · Started Apr 21, 2026 · Posted by FDA Jun 23, 2026

    Reason given: A snare catheter including luer lock, indicated for removal or manipulation of a foreign body in the vascular system, failed to meet the biocompatibility requirements for in-vitro-cytotoxicity, which if in contact with a patient's vasculature could result in localized inflammation and tissue irritation.

    Cause as FDA categorized it: Under Investigation by firm · Device type: Catheter, Embolectomy (DXE)

9 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.